(Press-News.org) In a viewpoint published this week in The Lancet, the Community Research Advisors Group (CRAG) argue that research into bedaquiline – a new drug, fast tracked for multidrug-resistant tuberculosis (MDR-TB) – should proceed cautiously in people with drug-sensitive tuberculosis. CRAG, an international, community-based advisory board for the US Centers for Disease Control and Prevention's Tuberculosis Trials Consortium, writing in The Lancet independently, urge researchers to balance the goal of shortening treatment for drug-sensitive TB with patient safety.
Bedaquiline is the first novel drug to be approved for treatment of tuberculosis in forty years. The FDA fast-tracked the approval of the drug after phase 2 studies showed bedaquiline's promising activity against MDR-TB (the drug reduced the average time to a negative TB culture from 18 to 12 weeks, and increased the proportion of participants with a negative culture at 6 months from 58% to 79%). Current treatments for drug-resistant tuberculosis show improved outcomes when continued for 18 to 24 months, and even then cure rates range from 11% to 79% depending on the extent of resistance. This presents a huge burden both on health care facilities and on patients to stick to a strict, toxic, and lengthy regimen, often in settings where available resources and cost make long drug treatments difficult to implement.
However, along with the potential benefits of bedaquiline, the authors point out that the drug presents several safety concerns that should be addressed before testing the drug in people with drug-sensitive TB, who already have a very effective treatment option and as such face different risk-benefit considerations than people with drug-resistant TB. In one phase 2 trial, a significantly higher number of participants receiving bedaquiline died than those receiving placebo. The majority of these deaths had no common cause and occurred months after the trial ended, but due to the long half-life of the drug, adverse effects from the drug cannot be ruled out. Close follow-up monitoring is needed due to an increased rate of liver and cardiac toxicity observed in patients receiving bedaquiline, say the authors.
The authors also call on the drug's developer, Janssen, to make information regarding the drug's safety available to public research groups, and to immediately begin trials on the effects of the drug in populations that use alcohol and drugs, and that have Hepatitis B and C. These groups could both benefit greatly from future shortened tuberculosis treatment regimens, but are also at a greater risk of some of the drug's reported side effects.
According to CRAG co-chair Dorothy Namutamba, "Although up to this point it has only been studied as an addition to existing regimens for drug-resistant tuberculosis, bedaquiline shows a lot of promise for improving treatment in the future. However, the drug also shows potentially serious adverse effects ranging from liver toxicity, disruption of the heart's electrical rhythm, and even death. As trials of this novel drug are considered in patients with drug-sensitive tuberculosis, researchers need to carefully balance the potential benefit of the new drug while making sure to always place the safety of the trial participants at the forefront of any considerations."*
INFORMATION:
NOTES TO EDITORS:
*Quote direct from author and cannot be found in text of Article
The Lancet: Novel treatment for drug-resistant tuberculosis shows promise, but concerns for patient safety remain
Community health experts call for balanced approach to continued development of promising new TB drug
2014-07-11
ELSE PRESS RELEASES FROM THIS DATE:
Cost of expensive medication in dialysis catheters may be offset by reduced complications
2014-07-11
Washington, DC (July 10, 2014) — Using an expensive agent to prevent blood clots in kidney failure patients' dialysis catheters may turn out to be less costly overall due to its ability to reduce medical complications, according to a study appearing in an upcoming issue of the Journal of the American Society of Nephrology (JASN).
Recombinant tissue plasminogen activator (rt-PA) is a medication used to break up blood clots that occur in the vessels of patients having a heart attack. A recent clinical trial revealed that using rt-PA once per week plus the anticlotting agent ...
High stress, hostility, depression linked with increased stroke risk
2014-07-10
Higher levels of stress, hostility and depressive symptoms are associated with significantly increased risk of stroke or transient ischemic attack (TIA) in middle-age and older adults, according to new research in the American Heart Association journal Stroke.
A TIA is a stroke caused by a temporary blockage of blood flow to the brain.
Researchers investigated how psychological factors might influence risk for chronic disease, using data from the Multi-Ethnic Study of Atherosclerosis (MESA), an ongoing study on cardiovascular disease risk factors in participants living ...
After a concussion, which teens will have emotional symptoms?
2014-07-10
CHICAGO – After a concussion, teens who are sensitive to light or noise may be more likely to also have emotional symptoms such as anxiety, according to a study released today that will be presented at The Sports Concussion Conference in Chicago, July 11 to 13, 2014, hosted by the American Academy of Neurology, the world's leading authority on diagnosing and managing sports concussion. The conference will feature the latest scientific advances in diagnosing and treating sports concussion from leading experts in the field.
The symptoms after a concussion can vary widely ...
Neutron crystallography solves long-standing biological mystery
2014-07-10
The controversy centres around a family of enzymes known as heme enzymes, due to the presence of a heme group in their active site. At the centre of the heme cofactor is an iron (Fe) atom, which becomes oxidised (ferryl) when a reacting heme is in an intermediate state called Compound I. The question that has remained unanswered for decades is whether this oxidation involves just an oxygen atom (O), or a hydroxyl group (OH). Resolving this fundamental question has implications for understanding oxidative processes within living cells, which is critically important for drug ...
Astronomers find 7 dwarf galaxies with new telescope
2014-07-10
Meet the seven new dwarf galaxies.
Yale University astronomers, using a new type of telescope made by stitching together telephoto lenses, recently discovered seven celestial surprises while probing a nearby spiral galaxy. The previously unseen galaxies may yield important insights into dark matter and galaxy evolution, while possibly signaling the discovery of a new class of objects in space.
For now, scientists know they have found a septuplet of new galaxies that were previously overlooked because of their diffuse nature: The ghostly galaxies emerged from the night ...
Study provides new approach to forecast hurricane intensity
2014-07-10
VIDEO:
This is the one-of-a-kind, Alfred C. Glassell, Jr., SUSTAIN research facility at the UM Rosenstiel School of Marine and Atmospheric Science, where Haus and colleagues will conduct further studies on...
Click here for more information.
MIAMI – New research from University of Miami (UM) Rosenstiel School of Marine and Atmospheric Science suggests that physical conditions at the air-sea interface, where the ocean and atmosphere meet, is a key component to improve forecast ...
Extinct sea scorpion gets a Yale eye exam, with surprising results
2014-07-10
Poor peepers are a problem, even if you are a big, bad sea scorpion.
One minute, you're an imperious predator, scouring the shallow waters for any prey in sight. The next, thanks to a post-extinction eye exam by Yale University scientists, you're reduced to trolling for weaker, soft-bodied animals you stumble upon at night.
Such is the lot of the giant pterygotid eurypterid, the largest arthropod that ever lived. A new paper by Yale paleontologists, published in the journal Biology Letters, dramatically re-interprets the creature's habits, capabilities, and ecological ...
Despite setback, 'Mississippi Baby' represents significant breakthrough in effort to end AIDS
2014-07-10
Washington, D.C.—July 10, 2014—In response to today's announcement that the "Mississippi Baby," believed to have been functionally cured of HIV, has now been found to have detectable levels of the virus, the Elizabeth Glaser Pediatric AIDS Foundation (EGPAF) expresses disappointment in this setback but remains hopeful that the scientific breakthrough that allowed the child's HIV levels to remain undetectable for more than two years will continue to help researchers understand how to control HIV and ultimately develop a cure.
"Although we had high hopes that the child ...
Hubble spots spiral bridge of young stars linking two ancient galaxies
2014-07-10
NASA's Hubble Space Telescope has photographed an unusual structure 100,000 light years long, which resembles a corkscrew-shaped string of pearls and winds around the cores of two colliding galaxies.
The unique structure of the star spiral may yield new insights into the formation of stellar superclusters that result from merging galaxies and gas dynamics in this rarely seen process.
"We were surprised to find this stunning morphology. We've long known that the 'beads on a string' phenomenon is seen in the arms of spiral galaxies and in tidal bridges between interacting ...
Active shooter training increases comfort level of emergency responders
2014-07-10
(Boston) – Emergency Medical Service (EMS) responders felt better prepared to respond to an active shooter incident after receiving focused tactical training according to a new study in the journal Prehospital and Disaster Medicine. This is the first study to specifically examine the EMS provider comfort level with respect to entering a scene where a shooter has not yet been neutralized or working with law enforcement personnel during that response.
Incidents such as the Columbine High School shooting, the Virginia Tech campus shooting, the 2009 Fort Hood shooting, the ...
LAST 30 PRESS RELEASES:
Can Hayabusa2 touchdown? New study reveals space mission’s target asteroid is tinier and faster than thought
Millisecond windows of time may be key to how we hear, study finds
Graz University of Technology opens up new avenues in lung cancer research with digital cell twin
Exoplanets are not water worlds
Study shows increasing ‘healthy competition’ between menu options nudges patients towards greener, lower-fat hospital food choices
New insights into melanoma plasticity uncover a critical role of iron metabolism
A graphene sandwich — deposited or transferred?
New light-powered motor fits inside a strand of hair
Oil rig study reveals vital role of tiny hoverflies
Children’s Hospital of Philadelphia researchers boost widespread use of dental varnish across pediatric network
iRECODE: A new computational method that brings clarity to single-cell analysis
New NUS-MOH study: Singapore’s healthcare sector carbon emissions 18% lower than expected, a milestone in the city-state’s net zero journey
QUT scientists create material to turn waste heat into clean power
Major new report sets out how to tackle the ‘profound and lasting impact’ of COVID-19 on cardiovascular health
Cosmic crime scene: White dwarf found devouring Pluto-like icy world
Major report tackles Covid’s cardiovascular crisis head-on
A third of licensed GPs in England not working in NHS general practice
ChatGPT “thought on the fly” when put through Ancient Greek maths puzzle
Engineers uncover why tiny particles form clusters in turbulent air
GLP-1RA drugs dramatically reduce death and cardiovascular risk in psoriasis patients
Psoriasis linked to increased risk of vision-threatening eye disease, study finds
Reprogramming obesity: New drug from Italian biotech aims to treat the underlying causes of obesity
Type 2 diabetes may accelerate development of multiple chronic diseases, particularly in the early stages, UK Biobank study suggests
Resistance training may improve nerve health, slow aging process, study shows
Common and inexpensive medicine halves the risk of recurrence in patients with colorectal cancer
SwRI-built instruments to monitor, provide advanced warning of space weather events
Breakthrough advances sodium-based battery design
New targeted radiation therapy shows near-complete response in rare sarcoma patients
Does physical frailty contribute to dementia?
Soccer headers and brain health: Study finds changes within folds of the brain
[Press-News.org] The Lancet: Novel treatment for drug-resistant tuberculosis shows promise, but concerns for patient safety remainCommunity health experts call for balanced approach to continued development of promising new TB drug